# MMR at 6 Months Trial

> **NCT03780179** · PHASE4 · COMPLETED · sponsor: **Rigshospitalet, Denmark** · enrollment: 6540 (actual)

## Conditions studied

- Meales-mumps-rubella Vaccine

## Interventions

- **BIOLOGICAL:** MMRvaxpro
- **BIOLOGICAL:** Placebo

## Key facts

- **NCT ID:** NCT03780179
- **Lead sponsor:** Rigshospitalet, Denmark
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-04-15
- **Primary completion:** 2022-01-07
- **Final completion:** 2022-01-07
- **Target enrollment:** 6540 (ACTUAL)
- **Last updated:** 2022-01-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03780179

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03780179, "MMR at 6 Months Trial". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT03780179. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*